BioCentury
ARTICLE | Strategy

Seeing the (En)light

January 19, 2012 8:00 AM UTC

AstraZeneca plc and Novo Nordisk A/S have come off the sidelines and joined up with Enlight Biosciences LLC, an entrepreneurial partnership that has established four platform technology companies in less than four years with input from its pharma partners.

Enlight was launched July 2008 with $39 million in funding from PureTech Ventures in collaboration with Merck & Co. Inc., Pfizer Inc. and Eli Lilly and Co...